Human Genetics

, Volume 128, Issue 4, pp 443–452

Susceptibility to chronic thromboembolic pulmonary hypertension may be conferred by miR-759 via its targeted interaction with polymorphic fibrinogen alpha gene

  • Zhiyong Chen
  • Toshiaki Nakajima
  • Nobuhiro Tanabe
  • Kunihiko Hinohara
  • Seiichiro Sakao
  • Yasunori Kasahara
  • Koichiro Tatsumi
  • Yoshinori Inoue
  • Akinori Kimura
Original Investigation

Abstract

A deletion/insertion (Del/Ins) polymorphism of 28 base pairs (bp) in the 3′ untranslated region (UTR) of fibrinogen alpha gene (FGA) was associated with thromboembolic diseases, but the underlying mechanisms remain unknown. Computational predication reveals that the 28 bp polymorphic fragment is complementary to the sequence of a microRNA, miR-759. In this study, we aim to investigate the association and implicated mechanisms between FGA polymorphisms and the susceptibility to chronic thromboembolic pulmonary hypertension (CTEPH). The Del/Ins polymorphism was analyzed in 190 patients with CTEPH and 628 controls. The FGA 3′UTR and miR-759 interaction was investigated using luciferase assay and quantitative RT-PCR method. Expression of miR-759 and FGA in human tissues was investigated by RT-PCR. The results reveal that the allele frequency of Ins was significantly higher in the patients than in the controls (55.8 vs. 47.1%, P = 0.003, odds ratio = 1.42, 95% confidence interval: 1.13–1.79). Both miR-759 and FGA were expressed in human liver. Co-transfection of miR-759 decreased the expression and mRNA stability of reporter gene containing the FGA 3′UTR. The effect of miR-759 was stronger on the Ins allele than on the Del allele. These observations suggest that the expression of FGA was regulated by miR-759 through its interaction at the polymorphic 3′UTR sequence, which was associated with the susceptibility to CTEPH.

References

  1. Applegate D, Haraga L, Hertzberg KM, Steben LS, Zhang JZ, Redman CM, Grieninger G (1998) The EC domains of human fibrinogen420 contain calcium binding sites but lack polymerization pockets. Blood 92:3669–3674PubMedGoogle Scholar
  2. Applegate D, Steben LS, Hertzberg KM, Grieninger G (2000) The alpha(E)C domain of human fibrinogen-420 is a stable and early plasmin cleavage product. Blood 95:2297–2303PubMedGoogle Scholar
  3. Carter AM, Catto AJ, Kohler HP, Ariens RA, Stickland MH, Grant PJ (2000) Alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism. Blood 96:1177–1179PubMedGoogle Scholar
  4. Carty CL, Cushman M, Jones D, Lange LA, Hindorff LA, Rice K, Jenny NS, Durda JP, Walston J, Carlson CS, Nickerson D, Tracy RP, Reiner AP (2008) Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults. The Cardiovascular Health Study. Thromb Haemost 99:388–395PubMedGoogle Scholar
  5. Fedullo PF, Auger WR, Kerr KM, Rubin LJ (2001) Chronic thromboembolic pulmonary hypertension. N Engl J Med 345:1465–1472CrossRefPubMedGoogle Scholar
  6. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9:102–114CrossRefPubMedGoogle Scholar
  7. Friedlander Y, Kark JD, Sinnreich R, Basso F, Humphries SE (2003) Combined segregation and linkage analysis of fibrinogen variability in Israeli families: evidence for two quantitative-trait loci, one of which is linked to a functional variant (−58G>A) in the promoter of the alpha-fibrinogen gene. Ann Hum Genet 67:228–241CrossRefPubMedGoogle Scholar
  8. Fu Y, Zhang JZ, Redman CM, Grieninger G (1998) Formation of the human fibrinogen subclass fib420: disulfide bonds and glycosylation in its unique (alphaE chain) domains. Blood 92:3302–3308PubMedGoogle Scholar
  9. Fuller GM, Zhang Z (2001) Transcriptional control mechanism of fibrinogen gene expression. Ann N Y Acad Sci 936:469–479CrossRefPubMedGoogle Scholar
  10. Grieninger G (2001) Contribution of the alpha EC domain to the structure and function of fibrinogen-420. Ann N Y Acad Sci 936:44–64CrossRefPubMedGoogle Scholar
  11. Hoeper MM, Mayer E, Simonneau G, Rubin LJ (2006) Chronic thromboembolic pulmonary hypertension. Circulation 113:2011–2020CrossRefPubMedGoogle Scholar
  12. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A (2008) Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA 105:7269–7274CrossRefPubMedGoogle Scholar
  13. Ko YL, Hsu LA, Hsu TS, Tsai CT, Teng MS, Wu S, Chang CJ, Lee YS (2006) Functional polymorphisms of FGA, encoding alpha fibrinogen, are associated with susceptibility to venous thromboembolism in a Taiwanese population. Hum Genet 119:84–91CrossRefPubMedGoogle Scholar
  14. Kominami S, Tanabe N, Ota M, Naruse TK, Katsuyama Y, Nakanishi N, Tomoike H, Sakuma M, Shirato K, Takahashi M, Shibata H, Yasunami M, Chen Z, Kasahara Y, Tatsumi K, Kuriyama T, Kimura A (2009) HLA-DPB1 and NFKBIL1 may confer the susceptibility to chronic thromboembolic pulmonary hypertension in the absence of deep vein thrombosis. J Hum Genet 54:108–114CrossRefPubMedGoogle Scholar
  15. Le Gal G, Delahousse B, Lacut K, Malaviolle V, Regina S, Blouch MT, Couturaud F, Mottier D, Oger E, Gruel Y (2007) Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism. Thromb Res 121:333–338CrossRefPubMedGoogle Scholar
  16. Levi M, Keller TT, van Gorp E, ten Cate H (2003) Infection and inflammation and the coagulation system. Cardiovasc Res 60:26–39CrossRefPubMedGoogle Scholar
  17. Lishko VK, Yakubenko VP, Hertzberg KM, Grieninger G, Ugarova TP (2001) The alternatively spliced alpha(E)C domain of human fibrinogen-420 is a novel ligand for leukocyte integrins alpha(M)beta(2) and alpha(X)beta(2). Blood 98:2448–2455CrossRefPubMedGoogle Scholar
  18. Lodish HF, Zhou B, Liu G, Chen CZ (2008) Micromanagement of the immune system by microRNAs. Nat Rev Immunol 8:120–130CrossRefPubMedGoogle Scholar
  19. Lv K, Guo Y, Zhang Y, Wang K, Jia Y, Sun S (2008) Allele-specific targeting of hsa-miR-657 to human IGF2R creates a potential mechanism underlying the association of ACAA-insertion/deletion polymorphism with type 2 diabetes. Biochem Biophys Res Commun 374:101–105CrossRefPubMedGoogle Scholar
  20. Ma J, Hennekens CH, Ridker PM, Stampfer MJ (1999) A prospective study of fibrinogen and risk of myocardial infarction in the Physicians’ Health Study. J Am Coll Cardiol 33:1347–1352CrossRefPubMedGoogle Scholar
  21. Mendell JT (2008) miRiad roles for the miR-17–92 cluster in development and disease. Cell 133:217–222CrossRefPubMedGoogle Scholar
  22. Mosesson MW, Siebenlist KR, Meh DA (2001) The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci 936:11–30CrossRefPubMedGoogle Scholar
  23. Rasmussen-Torvik LJ, Cushman M, Tsai MY, Zhang Y, Heckbert SR, Rosamond WD, Folsom AR (2007) The association of alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study. Thromb Res 121:1–7CrossRefPubMedGoogle Scholar
  24. Remijn JA, van Wijk R, de Groot PG, van Solinge WW (2001) Nature of the fibrinogen Aalpha gene TaqI polymorphism. Thromb Haemost 86:935–936PubMedGoogle Scholar
  25. Siegerink B, Rosendaal FR, Algra A (2009) Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke. J Thromb Haemost 7:385–390CrossRefPubMedGoogle Scholar
  26. Standeven KF, Grant PJ, Carter AM, Scheiner T, Weisel JW, Ariens RA (2003) Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function. Circulation 107:2326–2330CrossRefPubMedGoogle Scholar
  27. Suntharalingam J, Goldsmith K, van Marion V, Long L, Treacy CM, Dudbridge F, Toshner MR, Pepke-Zaba J, Eikenboom JC, Morrell NW (2008) Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension. Eur Respir J 31:736–741CrossRefPubMedGoogle Scholar
  28. Tanabe N, Kimura A, Amano S, Okada O, Kasahara Y, Tatsumi K, Takahashi M, Shibata H, Yasunami M, Kuriyama T (2005) Association of clinical features with HLA in chronic pulmonary thromboembolism. Eur Respir J 25:131–138CrossRefPubMedGoogle Scholar
  29. Tang H, Fu Y, Zhan S, Luo Y (2009) Alpha(E)C, the C-terminal extension of fibrinogen, has chaperone-like activity. Biochemistry 48(18):3967–3976CrossRefPubMedGoogle Scholar
  30. Yokoyama K, Zhang XP, Medved L, Takada Y (1999) Specific binding of integrin alpha v beta 3 to the fibrinogen gamma and alpha E chain C-terminal domains. Biochemistry 38:5872–5877CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Zhiyong Chen
    • 1
    • 2
  • Toshiaki Nakajima
    • 1
    • 3
  • Nobuhiro Tanabe
    • 4
  • Kunihiko Hinohara
    • 1
    • 3
  • Seiichiro Sakao
    • 4
  • Yasunori Kasahara
    • 4
  • Koichiro Tatsumi
    • 4
  • Yoshinori Inoue
    • 2
  • Akinori Kimura
    • 1
    • 3
  1. 1.Department of Molecular Pathogenesis, Medical Research Institute Tokyo Medical and Dental UniversityBunkyo-Ku, TokyoJapan
  2. 2.Department of Vascular and Applied Surgery, Graduate School of Medical and Dental SciencesTokyo Medical and Dental UniversityTokyoJapan
  3. 3.Laboratory of Genome Diversity, Graduate School of Biomedical Science Tokyo Medical and Dental UniversityTokyoJapan
  4. 4.Department of Respirology, Graduate School of MedicineChiba UniversityChibaJapan

Personalised recommendations